LIVER TRANSPLANT
Clinical trials for LIVER TRANSPLANT explained in plain language.
Never miss a new study
Get alerted when new LIVER TRANSPLANT trials appear
Sign up with your email to follow new studies for LIVER TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smartphone apps aim to boost health for transplant survivors
Disease control Recruiting nowThis study is testing whether a doctor-led lifestyle counseling program, supported by two personalized smartphone apps, is practical and helpful for older adults who have received a liver or kidney transplant. The program aims to improve healthy eating and physical activity habit…
Matched conditions: LIVER TRANSPLANT
Phase: NA • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
App aims to ease the tough transition for young liver transplant patients
Disease control Recruiting nowThis study is testing a new digital app designed to help young people (ages 14-20) who have had or are waiting for a liver transplant. The app helps them manage their health and medications, especially as they move from pediatric to adult care. Researchers want to see if the app …
Matched conditions: LIVER TRANSPLANT
Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for transplant patients whose liver cancer returns
Disease control Recruiting nowThis study is testing if the drug cabozantinib can help control liver cancer that has come back in people who previously had a liver transplant. The drug works by blocking proteins that help cancer tumors grow. About 20 participants will take the drug until it stops working or si…
Matched conditions: LIVER TRANSPLANT
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Could this treatment free liver transplant patients from lifelong medications?
Disease control Recruiting nowThis early-stage study is testing whether a combination of two drugs (everolimus and epoetin) can help stable liver transplant recipients safely reduce and potentially stop their lifelong anti-rejection medications. The goal is to help patients achieve 'operational tolerance' whe…
Matched conditions: LIVER TRANSPLANT
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Warm machine could unlock thousands more livers for transplant
Disease control Recruiting nowThis study is testing a special machine that keeps donor livers warm and functioning outside the body. The goal is to see if this machine can safely prepare moderately fatty livers, which are often discarded, for transplantation. If successful, this could significantly increase t…
Matched conditions: LIVER TRANSPLANT
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for transplant patients battling returned liver cancer
Disease control Recruiting nowThis study is testing whether a promising two-drug cancer treatment is safe for people whose liver cancer returned after a transplant. It will enroll 50 liver transplant patients to see if the treatment can control their advanced cancer without causing their body to reject the tr…
Matched conditions: LIVER TRANSPLANT
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Vaccine could shield transplant patients from dangerous virus
Prevention Recruiting nowThis study is testing whether a vaccine given before liver transplant surgery can prevent cytomegalovirus (CMV) infection afterward. The vaccine is being given to 416 people who need liver transplants and have never had CMV before. Researchers want to see if the vaccine reduces h…
Matched conditions: LIVER TRANSPLANT
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Apr 03, 2026 21:10 UTC
-
Could a tiny ear patch help fight the opioid crisis after surgery?
Symptom relief Recruiting nowThis study is testing if a small, disposable device placed on the ear can help reduce pain and the need for opioid painkillers after major abdominal or pelvic surgery. The device, called the NSS-2 BRIDGE, gently stimulates nerves in the ear, which may help calm pain pathways. Res…
Matched conditions: LIVER TRANSPLANT
Phase: NA • Sponsor: Jacques E. Chelly • Aim: Symptom relief
Last updated Apr 03, 2026 14:41 UTC
-
First-of-its-Kind study probes lifelong health of 'Transplant Babies'
Knowledge-focused Recruiting nowThis study aims to understand the long-term health of children born to mothers who have had a solid organ transplant (like kidney, liver, or heart). Researchers want to see if these children have a higher risk of heart, kidney, or immune system problems later in life, possibly du…
Matched conditions: LIVER TRANSPLANT
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists monitor transplant Patients' blood sugar to predict recovery
Knowledge-focused Recruiting nowThis study aims to understand how blood sugar levels after a liver transplant affect a patient's recovery and the long-term success of the transplant. Researchers will have 40 recent liver transplant patients wear a small, hidden glucose monitor for 30 days after leaving the hosp…
Matched conditions: LIVER TRANSPLANT
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC